TSP CAPITAL MANAGEMENT GROUP, LLC – Celldex Therapeutics, Inc. Transaction History
TSP CAPITAL MANAGEMENT GROUP, LLC portfolio value:
$7.51M
portfolio value
Celldex Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.28% | 750 shares | -7.17B | $28.11 | 267.29K |
| Q2 2022 | share | Decrease | -0.93% | -2.5K shares | -9.15B | $26.96 | 266.54K |
| Q1 2022 | share | Increase | +6.05% | 15.34K shares | -9.79B | $34.06 | 269.04K |
| Q4 2021 | share | Decrease | -6.53% | -17.73K shares | -14.65T | $38.9 | 253.69K |
| Q3 2021 | share | Decrease | -20.15% | -68.5K shares | 3.28M | $53.99 | 271.42K |
| Q2 2021 | share | Decrease | -5.37% | -19.3K shares | 3.96M | $33.44 | 339.92K |
| Q1 2021 | share | Decrease | -10.91% | -44K shares | 335K | $20.6 | 359.22K |
| Q4 2020 | share | Decrease | -8.72% | -38.5K shares | 514K | $17.52 | 403.22K |
| Q3 2020 | share | Increase | +20.05% | 73.76K shares | 1.76M | $14.83 | 441.72K |
| Q2 2020 | share | Decrease | -10.26% | -42.05K shares | 4.10M | $13 | 367.96K |
| Q1 2020 | share | Increase | +14.89% | 53.12K shares | -115K | $1.66 | 410.01K |
| Q4 2019 | share | Increase | +117.43% | 192.74K shares | 446K | $2.23 | 356.89K |
| Q3 2019 | share | Increase | +5.84% | 9.06K shares | -66K | $2.13 | 164.14K |
| Q2 2019 | share | Decrease | -0.85% | -1.33K shares | -354K | $2.68 | 155.08K |
| Q1 2019 | share | Increase | 0.00% | 156.41K shares | 770K | $4.92 | 156.41K |